Hepion Pharmaceuticals Inc.
10/02/2026 | Press release | Distributed by Public on 10/02/2026 07:25
Amendments to Bylaws (Form 8-K)
| Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On October 1, 2026, Hepion Pharmaceuticals, Inc. (the "Company") filed a Certificate of Amendment to the Company's Certificate of Incorporation (the "Certificate of Amendment") with the Secretary of State of the State of Delaware and the Certificate of Amendment became effective on filing. The Certificate of Amendment increased the authorized number of shares of common stock of the Company to 750,000,000. The foregoing description does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Hepion Pharmaceuticals Inc. published this content on October 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 02, 2026 at 13:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]